Literature DB >> 12800153

A new chromosome banding technique, spectral color banding (SCAN), for full characterization of chromosomal abnormalities.

Naoki Kakazu1, Irit Bar-Am, Satoshi Hada, Hiroatsu Ago, Tatsuo Abe.   

Abstract

We have developed spectral color banding (SCAN) as a new chromosome banding technique based on spectral analysis of differentially labeled chromosome band-specific painting probes. In this study, we succeeded in displaying a multicolor banding pattern for chromosome 3, which was almost identical to the pattern obtained with the corresponding G-banding. We applied this method to metaphase cells from different normal male donors with various levels of G-banding resolution, ranging from 250 to 850 bands per haploid set. The same multicolor banding pattern was observed in all samples regardless of the length of the chromosomes or the quality of the G-banding. We then used SCAN in a diffuse large B-cell lymphoma case for a complete analysis of the intrachromosomal change for chromosome 3, which could not be fully characterized by G-banding or even by spectral karyotyping (SKY). SCAN could detect the duplicated segment and identify the origin of the chromosome band on the basis of the specific spectral color of each band. This study demonstrates that SCAN is a useful tool for full characterization of chromosomal abnormalities not identified by SKY. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12800153     DOI: 10.1002/gcc.10229

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  3 in total

1.  Application of multicolor banding for identification of complex chromosome 18 rearrangements.

Authors:  Jie Hu; Malini Sathanoori; Sally J Kochmar; Urvashi Surti
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

2.  Clinical features of hypereosinophilic syndrome: FIP1L1-PDGFRA fusion gene-positive disease is a distinct clinical entity with myeloproliferative features and a poor response to corticosteroid.

Authors:  Keisuke Miyazawa; Naoki Kakazu; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2007-01       Impact factor: 2.490

3.  Multicolour-banding fluorescence in situ hybridisation (mbanding-FISH) to identify recurrent chromosomal alterations in breast tumour cell lines.

Authors:  A Letessier; M-J Mozziconacci; A Murati; J Juriens; J Adélaïde; D Birnbaum; M Chaffanet
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.